Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors.
Mario Orozco-MoralesAlejandro Avilés-SalasNorma Hernández-PedroRodrigo Catalán CárdenasGraciela Cruz-RicoAna Laura Colín-GonzálezElsa Dosal-MancillaPedro Barrios-BernalArrieta OscarPublished in: Journal of immunology research (2021)
Contrary to what happens in a wide range of hematologic and solid tumors, a higher expression of CD47 in patients with LNET is associated with a better progression-free survival, especially in patients with a Ki-67 ≥ 40%. This "paradox" remains to be confirmed and explained by larger studies.